Recall of Ebixa
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for specific batches of Ebixa (memantine hydrochloride; Lundbeck) 5mg/pump actuation 50ml and 100ml bottle. This is because of a fault with some of the pump devices which may result in suboptimal dosage of the product. Further information is available on the MHRA website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067474
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com